Serinus Biosciences
- Biotech or pharma, therapeutic R&D
Serinus Biosciences is an AI drug discovery company designing small molecule disrupters for protein-protein interactions (PPI). Our proprietary proteome-wide interface energetics map transforms any natural protein ligand into a small molecule binding opportunity.
With over 60% of the proteome estimated to have binding hot loops at small molecule scale, we are geared to reveal orthosteric docking sites in tens of thousands of previously undruggable targets. Together with our PPI-specific generative AI engine, we design potent and synthetically accessible interface binding hits in months instead of years.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}